Signal active
Organization
Contact Information
Overview
ByHeart operates as a fully integrated infant nutrition company. It is dedicated to translating leading nutrition science and breastmilk research into evolved foods and formulas to support babies’ health and parents’ peace of mind. Its products strive to be next to nature made from hand-picked ingredients using small-batch blending and sit at the forefront of immune, microbiome, cognitive, and digestive health.
The company was founded in 2016 and is headquartered in New York.
About
Biotechnology, Health Care, Wellness, Nutrition
2016
11-50
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
ByHeart headquartered in New York, New York, United States, North America, operates in the Biotechnology, Health Care, Wellness, Nutrition sector. The company focuses on Biotechnology and has secured $22.2B in funding across 80 round(s). With a team of 11-50 employees, ByHeart is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - ByHeart, raised $95.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
8
0
$277.0M
Details
3
ByHeart has raised a total of $277.0M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Early Stage Venture | 70.0M | ||
2021 | Early Stage Venture | 90.0M | ||
2024 | Late Stage Venture | 95.0M |
Investors
ByHeart is funded by 40 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Arie Belldegrun | - | FUNDING ROUND - Arie Belldegrun | 95.0M |
Bellco Capital | - | FUNDING ROUND - Bellco Capital | 95.0M |
ByHeart | - | FUNDING ROUND - ByHeart | 95.0M |
Red Sea Ventures | - | FUNDING ROUND - Red Sea Ventures | 95.0M |
Recent Activity
There is no recent news or activity for this profile.